Activity

  • Borch Singleton posted an update 2 weeks, 2 days ago

    To determine the incidence of abnormal renal function in an outpatient population referred for contrast-enhanced computed tomography (CECT) and assess the risk factors that could be used to eliminate superfluous estimated glomerular filtration rate (eGFR) testing.

    The following risk factors were assessed in random patients referred for outpatient CECT age >60 years, diabetes mellitus, hypertension, anemia, congestive heart failure, and a history of kidney/urological disease or renal surgery. The patients’ serum creatinine and eGFR levels, gender, and the type of CECT were recorded.

    The study included 500 patients (mean age 50±16 years). Among them, 36 (7.2%) patients had an eGFR <60 ml/min/1.73 m2 of which 31 (6.2%) had an eGFR of 59-45 ml/min/1.73 m2 and 5 (1%) patients an eGFR <45 ml/min/1.73 m2. No patients had an eGFR <30 ml/min/1.73 m2. There was a statistically significant association between an abnormal eGFR and age >60 years, diabetes mellitus, hypertension, and chronic kidney disease (p<0.05). By selecting only, the patients with one of the identified risk factors for eGFR assessment before CECT, all the patients with an abnormal eGFR (<60 ml/min/1.73 m2) were detected with sensitivity and a negative predictive value of 100%.

    Patients with an abnormal eGFR can be detected with sensitivity and a negative predictive value of 100% using our screening approach before CECT, and superfluous eGFR testing can thus be reduced by approximately 50% with concomitant cost savings. Outpatients without any risk factors should be excluded from routine renal function assessment before CECT.

    Patients with an abnormal eGFR can be detected with sensitivity and a negative predictive value of 100% using our screening approach before CECT, and superfluous eGFR testing can thus be reduced by approximately 50% with concomitant cost savings. Outpatients without any risk factors should be excluded from routine renal function assessment before CECT.

    To evaluate metabolic parameters of primary lesions examined by 18F-FDG PET/CT (18Fluorodeoxyglucose Positron Emission Tomography /Computed Tomography), including maximum standard uptake value (SUVmax), metabolic volume (MTV), and total lesion glycolysis (TLG).

    79 patients with endometrial cancer were selected as the subjects. They were diagnosed by histopathology in our hospital for the first time from January 2016 to December 2018. All the patients were examined by 18F-FDG PET/CT. Retrospective statistical analysis was carried out to evaluate different expression of metabolic parameters examined by 18F-FDG PET/CT of different clinicopathologic factors in endometrial cancer. Spearman correlation analysis was also used.

    SUVmax, TLG and MTV were correlated with FIGO staging, tissue grading, depth of myometrial invasion, and lymph node metastasis. SUVmax, TLG and MTV in lymph node metastasis group had high clinical staging, low differentiation and myometrial invasion depth >1/2, which were significantlrognosis of patients.

    Metabolic parameters of primary lesions examined by 18F-FDG PET/CT has a good correlation with its clinicopathological features. They can provide reference for the preoperative formulation of treatment plan for endometrial cancer, so as to reduce the risk of surgery and improve the prognosis of patients.

    Burns are one of the most commonly occurring soft tissue injuries worldwide. It has been reported that burns are associated with a higher prevalence of complications, mortality, and hospitalization-related outcomes in patients with coexisting diabetes mellitus. Moreover, the morbidity and mortality related outcomes associated with diabetes in patients with burns. However, since then, several studies reporting the prognostic role of diabetes in patients with burns have been published. Therefore, in this present study, we attempt to develop a current state of evidence evaluating the prognostic influence of diabetes mellitus on infectious complications, duration of hospital stay and mortality-related outcomes in patients with burns. The aim of the study is to determine the overall effect of diabetes mellitus on infectious complications, duration of hospital stay and mortality-related outcomes in patients with burns.

    We performed a systematic search of the academic literature in four academic databases included systematic review suggesting diabetes to be an important and independent risk factor delineating the prognostic outcome of burns.

    The present systematic review and meta-analysis provides evidence regarding the high morbidity and mortality related outcomes for diabetic patients with burns. The present study confirms the findings of a previously published systematic review suggesting diabetes to be an important and independent risk factor delineating the prognostic outcome of burns.Correction to European Review for Medical and Pharmacological Sciences 2021; 25 (3) 1198-1205-DOI 10.26355/eurrev_202102_24822-PMID 33629289, published online 15 February, 2021. After publication, the authors requested to correct Table I and some minor errors in the text. There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/24822.This paper presents several inaccuracies and mistakes. Therefore, the article “MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1, by R.-K. Zang, J.-B. Ma, Y.-C. Liang, Y. Wang, S.-L. Hu, Y. Zhang, W. Dong, W. buy DC661 Zhang, L.-K. Hu, published in Eur Rev Med Pharmacol Sci 2018; 22 (14) 4532-4541-DOI 10.26355/eurrev_201807_15508-PMID 30058693″ has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/15508.Since this paper presents several inaccuracies and mistakes, the article “LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p, by X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (24) 10761-10768-DOI 10.26355/eurrev_201912_19778-PMID 31858543” has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/19778.

Subscribe to MG Dating

MG Dating offers you the opportunity to simply accelerate this process by finding out which is your life partner.

Register Now

Copyright © 2022 MG Dating

0